GSK chases next biotech asthma drug with $230 million J&J deal

[ahlam1399]

GSK chases next biotech asthma drug with $230 million J&J deal

GSK chases next biotech asthma drug with 0 million J&J deal
LONDON (Reuters) - GlaxoSmithKline has bought global rights to an experimental drug from Johnson & Johnson for up to 175 million pounds ($230 million), raising its bet on a new generation of biotech medicines for severe asthma.

??????? ??????: GSK chases next biotech asthma drug with $230 million J&J deal || ??????: ahlam1399 || ??????: اسم منتداك

https://hameed.nwar.uk/vb

كلمات البحث

العاب ، برامج ، سيارات ، هاكات ، استايلات